Get the app
US › Healthcare

Lisata Therapeutics Inc. (LSTA)

US · Healthcare · Biotechnology

$1.03-3.74%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Revenue YoY
-100.0%
Net profit
$-2.9M
EPS
$-0.54

Key statistics

Market cap
$11.5M
Forward P/E
2.7
P/B
1.94
Book value
$0.90
EPS (TTM)
$-1.64
52-week high
$5.07
52-week low
$0.99
50-day MA
$1.42
200-day MA
$3.06
Beta
0.94

Analyst view

Analysts rate Lisata Therapeutics Inc. a hold (0 buy, 2 hold, 0 sell out of 2) with an average price target of $4.00.

Shareholding

Insiders
22.26%
Institutions
11.14%

Largest institutional holders

FundStake
Deeter Investments LLP3.37%
Vanguard Capital Management, LLC2.58%
Yakira Capital Management, Inc.1.28%
Css LLC1.02%
Deltec Asset Management LLC0.77%
Geode Capital Management, LLC0.67%
Virtu Financial LLC0.54%
BlackRock Inc0.51%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Lisata Therapeutics Inc. — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.